ONGAVIA

View On IC.GC.CA

APPROVED

on 29 Jan 2025

Last Applicant/ Owned by

TEVA Pharmaceutical Industries Limited

124 Dvora HaNevi'a6944020 Tel Aviv-Jaffa

Serial Number

2131327 filed on 2^th Sept 2021

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

ONGAVIA

Trademark usage description

pharmaceutical preparations for the treatment of multiple sclerosis, lupus nephritis and crohn's disease.

Classification Information

2131327

Trademark

Action Taken	Status
Submitted for opposition 42 on 29^th Jan 2025	Advertised
Submitted for opposition 27 on 31^st Dec 2024	Approval Notice Sent
Submitted for opposition 26 on 31^st Dec 2024	Approved
Submitted for opposition 22 on 19^th Dec 2024	Search Recorded
Submitted for opposition 287 on 8^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 135 on 28^th Feb 2022	Amendment to Application
Submitted for opposition 30 on 2^th Sept 2021	Filed
Submitted for opposition 1 on 2^th Sept 2021	Created
Submitted for opposition 31 on 2^th Sept 2021	Formalized